Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients

Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients

Objective: We evaluated the correlation between benign prostate hyperplasia (BPH) measures and diabetes mellitus in men with benign prostate hyperplasia in a prospective study. Materials and methods: Between 2008-2012, 100 diabetic and 200 non diabetic patients undergoing surgery due to benign prost...

Full description

Bibliographic Details
Main Authors:	Levent Ozcan, Huseyin Besiroglu, Murat Dursun, Emre Can Polat, Alper Otunctemur, Emin Ozbek
Format:	Article
Language:	English
Published:	PAGEPress Publications 2017-03-01
Series:	Archivio Italiano di Urologia e Andrologia
Subjects:	Benign prostate hyperplasia Diabetes International prostate symptom score Prostate volume Prostatic Specific Antigen (PSA) Testosterone
Online Access:	http://www.pagepressjournals.org/index.php/aiua/article/view/6014

Similar Items

Estimation of Testosterone, Estradiol and some Markers in Sera of Iraqi Patients with Benign Prostatic Hyperplasia.
by: Baghdad Science Journal
Published: (2013-12-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

Comparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patients
by: D.E. Orakwe, et al.
Published: (2017-06-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role
by: Cochetti G, et al.
Published: (2016-12-01)

Relationship between serum prostate-specific antigen and transrectal prostate sonographic findings in asymptomatic Ugandan males
by: Maxwell Okuja, et al.
Published: (2021-04-01)

Monotherapy versus combination therapy in the treatment of benign prostatic hyperplasia: A single center study
by: Wishyar Jamal Al-Bazzaz, et al.
Published: (2020-12-01)

Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01)

EFEK KATETER TERHADAP FUNGSI PSA SERUM SEBAGAI PREDIKTOR VOLUME PROSTAT PADA PASIEN YANG TERBUKTI BENIGN PROSTATIC HYPERPLASIA PADA PEMERIKSAAN HISTOPATOLOGIS
by: Untung Tranggono, et al.
Published: (2014-09-01)

Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet
by: Omowumi Titilola Kayode, et al.
Published: (2020-12-01)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
by: Sung Han Kim, et al.
Published: (2021-04-01)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
by: Ida Bagus O.W. Putra, et al.
Published: (2016-06-01)

Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
by: Priya Duvedi, et al.
Published: (2019-05-01)

Effect of Chronic Prostatitis on Angiogenic Activity and Serum Prostate Specific Antigen Level in Benign Prostatic Hyperplasia
by: Resit Dogan Koseoglu, et al.
Published: (2007-08-01)

Frequency of common complications during treatment of patients with benign prostate hyperplasia
by: Kričković Zoran, et al.
Published: (2020-01-01)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
by: Jin-Woo Jung, et al.
Published: (2019-01-01)

An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy
by: Aditya Srinivasan, et al.
Published: (2020-10-01)

Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
by: Da Silva MHA, et al.
Published: (2019-01-01)

Outcome of Surgery for Benign Prostatic Hyperplasia-Is It Predictable?
by: Suhani, et al.
Published: (2013-12-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Comparative analysis of biological profiles of benign prostate hyperplasia and prostate cancer as potential diagnostic, prognostic and predictive indicators
by: Hanna Andrusewicz, et al.
Published: (2011-10-01)

One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
by: Prarthana B Desai, et al.
Published: (2017-01-01)

THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01)

Comparison of the rate of complications after TUEB and cystic prostatectomy in patients with benign prostatic hyperplasia
by: G. V. Bachurin
Published: (2013-08-01)

Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients
by: Xian-Tao Zeng, et al.
Published: (2018-09-01)

Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)

Giant prostatic hyperplasia and its causes
by: Marius Anglickis, et al.
Published: (2020-04-01)

The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride
by: Konstantinos N. Stamatiou, et al.
Published: (2008-10-01)

Cadmium Concentration and Metallothionein Expression in Prostate Cancer and Benign Prostatic Hyperplasia of Humans
by: Jane-Dar Lee, et al.
Published: (2009-07-01)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
by: Lee WC, et al.
Published: (2013-11-01)

Amelioration of Benign Prostatic Hyperplasia by Costunolide and Dehydrocostus Lactone in Wistar Rats
by: Dohyun Choi, et al.
Published: (2021-04-01)

The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective
by: Teow J. Phua
Published: (2021-06-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: N. B. Tabynbaev, et al.
Published: (2017-05-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Accurate Cut-off Point for Free to Total Prostate- Specific Antigen Ratio Used to Improve Differentiation of Prostate Cancer from Benign Prostate Hyperplasia in Iranian Population
by: Khosro Rahbar, et al.
Published: (2010-05-01)

The Influencing Role of Diabetes Mellitus and Hypertension in the Establishment of Benign Prostatic Hyperplasia
by: Ram Sagar Shah, et al.
Published: (2020-06-01)

The Effects of 8-Week Endurance Training on Prostatic Autophagy and Benign Prostatic Hyperplasia of Rats
by: Dong-Won Lee, et al.
Published: (2019-08-01)

THE INCIDENCE AND CORRELATION OF CHRONIC PROSTATITIS WITH PSA IN BPH PATIENT
by: Daniel Mahendra Krisna, et al.
Published: (2018-07-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

Evaluation of Prostate specific antigen levels and its correlation with histopathological findings
by: Sujata Pudasaini, et al.
Published: (2019-03-01)